SMARCB1 and atypical teratoid rhabdoid tumor: NCH-MN-1 was derived from a patient diagnosed with an anaplastic rhabdoid meningioma with the clinical suspicion of an ATRT; however, this model had no evidence of an inactivating SMARCB1 alteration.